Greenfire Bio
Greenfire Bio is a life science development and investment company based in Austin, Texas, founded in 2020. The firm focuses on building a diversified product pipeline by developing early-stage assets through proof of concept. Greenfire Bio engages in licensing, acquiring, partnering, or investing in unique pre-clinical or early clinical-stage programs. Its goal is to bridge the translational medicine gap and accelerate the development of innovative medical breakthroughs. The company is led by a team of experienced biopharma executives who aim to foster advancements in healthcare through strategic investments and collaborations.
1 past transactions
Pacylex
Series A in 2021
Pacylex Pharmaceuticals is a biotechnology company based in Edmonton, Alberta, Canada, founded in 2012. The company specializes in developing precision medicine solutions for various cancers, focusing on both blood and solid tumors. Its flagship product, PCLX-001, is an oral chemotherapeutic agent designed to induce selective lethality in cancer cells by targeting membrane-associated proteins involved in cancer signaling. This innovative approach not only provides a potent alternative to traditional chemotherapies and immunotherapies but also incorporates diagnostic technology to identify patients who are most likely to benefit from the treatment. By doing so, Pacylex aims to reduce unnecessary treatments for many patients while advancing the field of cancer therapy with a first-in-kind drug.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.